Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Id | http://purl.obolibrary.org/obo/NCIT_C29271
http://purl.obolibrary.org/obo/NCIT_C29271
|
|---|---|
| Preferred Name | Mupirocin |
| Definitions |
A natural crotonic acid derivative extracted from Pseudomonas fluorescens. Mupirocin inhibits bacterial protein synthesis by specific reversible binding to bacterial isoleucyl tRNA synthase. With excellent activity against gram-positive staphylococci and streptococci, it is primarily used for treatment of primary and secondary skin disorders, nasal infections, and wound healing. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A natural crotonic acid derivative extracted from Pseudomonas fluorescens. Mupirocin inhibits bacterial protein synthesis by specific reversible binding to bacterial isoleucyl tRNA synthase. With excellent activity against gram-positive staphylococci and streptococci, it is primarily used for treatment of primary and secondary skin disorders, nasal infections, and wound healing. (NCI04) |
|---|---|
| label |
Mupirocin
|
| prefLabel |
Mupirocin
|
| Legacy Concept Name |
Mupirocin
|
| in_subset | |
| Preferred_Name |
Mupirocin
|
| Chemical_Formula |
C26H44O9
|
| UMLS_CUI |
C0085259
|
| FDA_UNII_Code |
D0GX863OA5
|
| prefixIRI |
NCIT:C29271
|
| Contributing_Source |
FDA
|
| subClassOf | |
| Has_Salt_Form | |
| code |
C29271
|
| type | |
| Semantic_Type |
Pharmacologic Substance
|
| CAS_Registry |
12650-69-0
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |